Sign in

NCT07047482Recruiting

Clinicopathological Value of p16 Expression in Colorectal Carcinoma

Clinicopathological Value of p16 Expression in Colorectal Carcinoma: An Immunohistochemical Study.

Source: ClinicalTrials.gov · Last updated 10 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
24 Jun 2025
Start date
1 May 2025
Primary completion date
21 Mar 2026
Lead sponsor
Sohag University
NCT number
NCT07047482

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 1 May 2025 to the primary completion date, 21 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Tissue blocks with insufficient, destroyed or necrotic material.
  • Specimens with insufficient clinical data.

Who the study is looking for

  • Specimens from patients with colorectal cancer.
  • Tissue blocks with sufficient material.
  • Specimens with sufficient clinical data.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine
Coordinator of this site? Confirm its status		SohagEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.